A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
Clinical trial NCT01171313 · COMPLETED
Trial details
- NCT number
- NCT01171313
- Sponsor
- XenoPort, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.